10 facts about what FDA does and does not approve
While gastroparesis is rare, its important to be aware of this potential risk and seek help if you notice severe or persistent symptoms
LLY also announced in mid-February 2024 that a phase 2 trial evaluating tirzepatide for liver disease metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), met its primary endpoint where up to 74% of participants achieved resolution of MASH with no worsening of fibrosis, compared to 13% on placebo
Campbell JE, Drucker DJ
OstroVit also produces healthy oils, peanut butter, spices, zero calorie sauces, OstroVit, OstroVit high-protein noodles and food flavors
Scandinavian researchers gave people rice pudding with and without one or three grams of cinnamon, which is about a third of a teaspoon, or a full teaspoon